Summary
The distribution of drugs into the cerebrospinal fluid has long been considered a challenging field of investigation in 2 major respects: (a) understanding how the physicochemical properties (molecular weight, pKa, plasma protein binding) of various molecules influence their movements across such a specific structure as the blood-brain barrier; and (b) defining the relationship between cerebrospinal fluid concentrations of various drugs and their central (side) effects. An attempt has been made to review the very dispersed information presently available to offer a clinically orientated picture of this area of pharmacokinetics. Drugs acting on the central nervous system (benzodiazepines, tricyclic antidepressants, anticonvulsants, opioids), antibacterial agents, cardiovascular drugs (β-adrenoceptor blockers and digoxin), antineoplastic drugs (mainly methotrexate), and other miscellaneous agents (corticosteroids, cimetidine, methylxanthines) are reviewed.
The available evidence seems to support the conclusion that only for methotrexate and antibacterial agents does knowledge of cerebrospinal fluid pharmacokinetics have direct therapeutic implications, while the mosaic of information available for other drugs does little more than provide a partially satisfactory picture.
Similar content being viewed by others
References
Aaltonen, L.; Kanto, J. and Salo, M.: Cerebrospinal fluid concentrations and serum protein binding of lorazepam and its conjugate. Acta Pharmacologica et Toxicologica 46: 156–158 (1980).
Aaltonen, L.; Kanto, J.; Iisalo, E.; Koski, K.; Salo, M. and Siirtola, T.: The passage of flunitrazepam into cerebrospinal fluid in man. Acta Pharmacologica et Toxicologica 48: 364–368 (1981).
Addiego, J.E.; Ridgway, D. and Bleyer, W.A.: The acute management of intrathecal methotrexate overdose: Pharmacologic rationale and guidelines. Journal of Pediatrics 98: 825–830 (1981).
Agurell, S.; Boréus, L.O.; Gordon, E.; Lindgren, J.E.; Ehrnebo, M. and Lonroth, U.: Plasma and cerebrospinal fluid concentrations of pentazocine in patients: Assay by mass fragmentography. Journal of Pharmacy and Pharmacology 26: 1–8 (1974).
Alberti, E.; Hartmann, A.; Schütz, H.-J. and Schreckenberger, F.: The effect of large doses of dexamethasone on the cerebrospinal fluid pressure in patients with supratentorial tumors. Journal of Neurology 217: 173–181 (1978).
Allonen, H.; Andersson, K.-E.; Iisalo, E.; Kanto, J.; Strömblad, L.-G. and Wettrell, G.: Passage of digoxin into cerebrospinal fluid in man. Acta Pharmacologica et Toxicologica 41: 193–202 (1977).
Aranda, J.V. and Turmen, T.: Methylxanthines in apnea of prematurity. Clinical Perinatology 6: 87–108 (1979).
Arias, I.M.: Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. Journal of Clinical Investigation 41: 2233–2245 (1962).
Bakay, L.: Changes in barrier effect in pathological states. Progress in Brain Research 29: 315–341 (1968).
Barling, R.W.A. and Selkon, J.B.: The penetration of antibiotics into cerebrospinal fluid and brain. Journal of Antimicrobial Chemotherapy 4: 203–227 (1978).
Barlow, C.F.: Clinical aspects of the blood-brain barrier. Annual Review of Medicine 15: 187–202 (1964).
Barlow, C.F.: Physiology and pathophysiology of protein permeability in the central nervous system; in Reulen and Schürmann (Eds) Steroids and Brain Edema, pp.139–146 (Springer Verlag, Berlin 1972).
Behar, M.; Magora, F.; Olshwang, D. and Davidson, J.T.: Epidural morphine in treatment of pain. Lancet 1: 527–529 (1979).
Bellantuono, C.; Reggi, V.; Tognoni, G. and Garattini, S.: Benzodiazepines: Clinical pharmacology and therapeutic use. Drugs 19: 195–219 (1980).
Bering, E.A.: The cerebrospinal fluid and the extracellular fluid of the brain. Federation Proceedings 33: 2061–2063 (1974).
Berkowitz, B.A.: The relationship of pharmacokinetics to pharmacological activity: Morphine, methadone and naloxone. Clinical Pharmacokinetics 1: 219–230 (1976).
Berndt, S.F. and Führmeister, U.: Cerebrospinal fluid levels of cortisol, prednisolone and dexamethasone following intravenous and intrathecal injection in man. Archives of Pharmacology 279 (Suppl.): R51 (1973).
Bertilsson, L.; Braithwaite, R.; Tybring, G.; Garle, M. and Borga, O.: Techniques for plasma protein binding of demethylchlorimipramine. Clinical Pharmacology and Therapeutics 26: 265–271 (1979).
Bertler, A.; Falck, B.; Owman, Ch. and Rosengrenn, E.: The localization of monoaminergic blood-brain barrier mechanisms. Pharmacological Reviews 18: 369–385 (1966).
Bertler, A.; Andersson, K.-E. and Wettrell, G.: Concentration of digoxin in choroid plexus. Lancet 2: 1453–1454 (1973).
Blackwood, W.; McMenemy, W.H.; Meyer, A.; Norman, R.M. and Russell, D.S.: in Greenfield’s Neuropathology (Williams and Wilkins, Baltimore 1963).
Blanc, W.A. and Johnson, L.: Studies on kernicterus. Relationship with sulfonamide intoxication; report on kernicterus in rats with glucuronyl transferase deficiency, and a review of pathogenesis. Journal of Neuropathology and Experimental Neurology 18: 165–189 (1959).
Bleyer, W.A. and Dedrick, R.L.: Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injections. Cancer Treatment Reports 61: 703–708 (1977).
Bleyer, W.A.; Poplack, D.G. and Simon, R.M.: ‘Concentration X time’ methotrexate via a subcutaneous reservoir: A less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 51: 835–842 (1978).
Blinding, A.: Effects of different rates of absorption of two benzodiazepines on subjective and objective parameters. Significance of clinical use and risk of abuse. European Journal of Clinical Pharmacology 7: 201–211 (1974).
Blom, G.F. and Guelen, P.J.M.: The distribution of antiepileptic drugs between serum, saliva and cerebrospinal fluid; in Gardner-Thorpe et al. (Eds) Antiepileptic Drug Monitoring, pp.287–297 (Pitman Medical, London 1977).
Bonati, M.; Latini, R.; Marra, G.; Assael, B.M. and Parini, R.: Theophylline distribution in the premature neonate. Developmental Pharmacology and Therapeutics 3: 65–73 (1981)
Bond, A.J. and Lader, M.: Residual effects of hypnotics. Psychopharmacologia 25: 117–132 (1972).
Böning, J. and Holzbach, E.: Immunologic diagnostic of blood CSF barrier in the course of delirium tremens. Archiv fur Psychiatrie und Nervenkrankeiten (Berlin) 227: 319–328 (1979).
Bourke, R.S.: The effect of route and rate of administration of 5-fluorouracil on subsequent distribution in brain and cerebrospinal fluid: An experimental study; in Sinks and Godden (Eds) Conflicts in Childhood Cancer: An Evaluation of Current Management, pp.395–399 (Alan Liss, New York 1975).
Bratlid, D. and Fog, J.: The binding capacity of human albumin for bilirubin and its significance in the pathogenesis of kernicterus. Scandinavian Journal of Clinical and Laboratory Investigation 25: 257–261 (1970).
Braun, L.D.; Cornford, E.M. and Oldendorf, W.H.: Newborn rabbit blood-brain barrier is selectively permeable and differs substantially from the adult. Journal of Neurochemistry 34: 147–152 (1980).
Broder, L.E. and Carter, S.K.: Meningeal Leukemia (Plenum Press, New York 1972).
Broman, T. and Lindberg-Broman, A.M.: An experimental study of disorders in the permeability of the cerebral vessels (’the blood-brain barrier’) produced by chemical and physico chemical agents. Acta Physiologica Scandinavica 10: 102–125 (1945).
Brown, T.C.K.: Pediatric pharmacology. Anaesthesia and Intensive Care 1: 473–479 (1973).
Brynskow, J.; Thyssen, H.; Jansen, E. and Munster-Swendsen, J.: Cimetidine and Romberg’s test. Lancet 1: 1421 (1980).
Cangiano, C.; Cascino, A.; Fiaccadori, F.; Riggio, O.; Rossi Fanelli, F. and Capocaccia, L.: Is the blood-brain barrier really intact in portal-systemic encephalopathy? Lancet 1: 1367 (1981).
Christensen, J.M. and Holfort, S.: Methaqualone in human serum and cerebrospinal fluid after oral intake. Journal of Pharmacy and Pharmacology 27: 538–539 (1975).
Clarke, I.M. and Tempest, S.M.: Opiate doses for terminal cancer. Lancet 1: 373–374 (1980).
Cohen, E.N.: Blood-brain barrier to d-tubocurarine. Journal of Pharmacology and Experimental Therapeutics 141: 356–362 (1963).
Cohen, S.: The immune response in relation to the nervous system; in Cumings and Kremer (Eds) Biochemical Aspects of Neurological Disorders, 3rd Series, pp. 10–22 (Blackwell, Oxford 1968).
Corbeel, L.; de Boeck, K.; Logghe, N.; Eggermont, E.; Eeckels, R.; Casaer, P.; Vandepitte, J. and Verbist, L.: Intraventricular gentamicin in meningitis. Lancet 2: 252–253 (1980).
Cousins, M.J.; Mather, L.E.; Glynn, C.J.; Wilson, P.R. and Graham, J.R.: Selective spinal analgesia. Lancet 1: 1141–1142 (1979).
Craft, J.C.; Feldman, W.E. and Nelson, J.D.: Clinicopharmacological evaluation of amoxicillin and probenecid against bacterial meningitis. Antimicrobial Agents and Chemotherapy 16: 346–352 (1979).
Dacey, R.G. and Sande, M.A.: Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrobial Agents and Chemotherapy 6: 437–441 (1974).
Davson, H.: Physiology of the Cerebrospinal Fluid (Little, Brown Co, Boston 1967).
Davson, H.: The blood brain barrier; in Bourne (Ed) The Structure and Function of Nervous Tissue vol. IV, pp.321–445 (Academic Press, New York 1972).
Davson, H. and Smith, H.V.: Discussion on the penetration of drugs into the central nervous system. Proceedings of the Royal Society of Medicine 50: 963–966 (1957).
de Louvois, J.: The bacteriology and chemotherapy of brain abscess. Journal of Antimicrobial Chemotherapy 4: 395–413 (1978).
Dewhurst, K.: The use of probenecid for increasing penicillin concentrations in cerebrospinal fluid. Acta Neurologica Scandinavica 45: 253–256 (1969).
Diamond, I. and Schmid, R.: Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. Journal of Clinical Investigation 45: 678–689 (1966).
Dinsdale, H.B.; Robertson, D.M.; Haas, R.A. and Davis, P.E.: Acute hypertension, blood-brain barrier damage, and the role of adrenal steroids; in Cervos-Navarro et al. (Eds) The Cerebral Vessel Wall, pp.253–260 (Raven Press, New York 1976).
Dixon, R.L.; Owens, E.S. and Rall, D.P.: Evidence of active transport of benzyl-14C penicillin from cerebrospinal fluid to blood. Journal of Pharmaceutical Sciences 58: 1106–1109 (1969).
Dobbing, J.: The development of the blood-brain barrier. Progress in Brain Research 29: 417–427 (1968).
Dobbing, J.: The blood-brain barrier. Lancet 2: 584 (1981).
Done, A.K.: Developmental pharmacology. Clinical Pharmacology and Therapeutics 5: 432–479 (1964).
Done, A.K.; Cohen, S.N. and Strebet, L.: Pediatric clinical pharmacology and the ‘therapeutic orphan’. Annual Review of Pharmacology and Toxicology 17: 561–573 (1977).
Dundee, J.W. and McCaughey, W.: Drugs in anaesthetic practice; in Avery (Ed) Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics, 2nd ed., pp.282–334 (ADIS Press, Sydney 1980).
Dunlop, E.M.; Al-Egaily, S.S. and Houang, E.T.: Penicillin levels in the blood and CSF achieved by treatment of syphilis. Journal of the American Medical Association 241: 2538–2540 (1979).
Dunlop, E.M.C.: Production of treponemicidal concentration of penicillin in cerebrospinal fluid. British Medical Journal 283: 646 (1981).
Editorial: Epidural opiates. Lancet 1: 962-963 (1980).
Editorial: Antibacterial chemotherapy in the newborn. Drug and Therapeutics Bulletin 19: 13–16 (1981).
Elliott, H.W.: Metabolism of lorazepam. British Journal of Anaesthesiology 48: 1017–1023 (1976).
Elwan, O. and Adam, H.K.: Relationship between blood and cerebrospinal levels of the antidepressant agent viloxazine. European Journal of Clinical Pharmacology 17: 179–182 (1980).
Engquist, A.; Chraemmer Jørgensen, B. and Andersen, H.B.: Epidural morphine-induced catatonia. Lancet 2: 984 (1980).
Eyster, E.F.; Nielsen, S.L.; Sheline, G.E. and Wilson, C.B.: Cerebral radiation necrosis simulating a brain tumor. Case report. Journal of Neurosurgery 40: 267–271 (1974).
Ferngren, H.: Brain and blood levels of phenobarbital-2-14C during postnatal development in the mouse. Acta Pharmaceutica Suecica 6: 331–338 (1969).
Firemark, H.; Barlow, C.F. and Roth, L.J.: The entry, accumulation and binding of diphenylhydantoin-2-C14 in brain. International Journal of Neuropharmacology 2: 25–38 (1963).
Fishman, R.A.: Blood-brain and CSF barriers to penicillin and related organic acids. Archives of Neurology 15: 113–124 (1966).
Foley, K.M. and Inturrisi, C.E.: Intrathecal beta-endorphin. Lancet 2: 317 (1980).
Folkman, J.: Tumor angiogenesis: Therapeutic implications. New England Journal of Medicine 285: 1182–1186 (1971).
Frederiksen, W, and Schouenborg, P.: Intraventricular gentamicin in meningitis (corresp.). Lancet 2: 253 (1980).
Friis, M.L.; Christiansen, J. and Hvidberg, E.F.: Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients. European Journal of Clinical Pharmacology 14: 47–51 (1978).
Friis-Hansen, B.: Body composition during growth. Pediatrics 47: 264–274 (1971).
Godtfredsen, W.; Roholt, K. and Tybring, L.: Fucidin. A new orally active antibiotic. Lancet 1: 928–931 (1962).
Goldsmith, M.A. and Carter, S.K.: Glioblastoma multiforme: A review of therapy. Cancer Treatment Reviews 1: 153–165 (1974).
Gram, L.F.: Plasma level monitoring of tricyclic antidepressant therapy. Clinical Pharmacokinetics 2: 237–251 (1977).
Gundert-Remy, U.; Klett, M. and Weber, E.: Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein bound drug fraction in serum. European Journal of Clinical Pharmacology 6: 133–136 (1973).
Gustafsson, L.L.; Feychting, B. and Klingstedt, C.: Late respiratory depression after concomitant use of morphine epidurally and parenterally. Lancet 1: 892–893 (1981).
Hallström, C.; Lader, M.H. and Curry, S.H.: Diazepam and N-desmethyldiazepam concentrations in saliva, plasma and CSF. British Journal of Clinical Pharmacology 9: 333–339 (1980).
Harvey, S.C.: Hypnotics and sedatives; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, 6th ed., pp.339–375 (Macmillan, London 1980).
Hawkins, R.A.; Mans, A.M. and Biebuyck, J.F.: Blood-brain barrier during portal-systemic encephalopathy. Lancet 2: 302 (1981a).
Hawkins, R.A.; Mans, A.M. and Biebuyck, J.F.: The blood-brain barrier. Lancet 2: 584–585 (1981b).
Hayakawa, T.; Ushio, Y.; Morimoto, K.; Hasegawa, H.; Mogami, H. and Horibata, K.: Uptake of bleomycin by human brain tumours. Journal of Neurology, Neurosurgery and Psychiatry 39: 341–349 (1976).
Heel, R.C.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Buprenorphine: A review of its pharmacological properties and therapeutic efficacy. Drugs 17: 81–110 (1979).
Hendel, J.: Cumulation in cerebrospinal fluid of the N-demethyl-metabolite after long-term treatment with diazepam in man. Acta Pharmacologica et Toxicologica 37: 17–22 (1975).
Hindersin, P. and Heidrich, R.: Hemostatic processes in aneurysmal hemorrhages. Psychiatrie, Neurologie und Medizinische Psychologie (Leipzig) 29: 129–144 (1977).
Horrocks, L.A.: Composition and metabolism of myelin phosphoglycerides during maturation and aging. Progress in Brain Research 40: 383–395 (1973).
Houghton, G.W.; Richens, A.; Toseland, P.A.; Davidson, S. and Falconer, M.A.: Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients. European Journal of Clinical Pharmacology 9: 73–78 (1975).
Humphrey, G.B.; Krous, H.F.; Filler, J.; Maxwell, J.D. and Van Houtte, J.J.: Treatment of overt CNS leukemia. American Journal of Pediatric Hematology/Oncology 1: 37–47 (1979).
Iisalo, E.: Clinical pharmacokinetics of digoxin. Clinical Pharmacokinetics 2: 1–16 (1977).
Ivanov, K.S. and Verovaia, A.V.: Effect of euphylline and caffeine on the permeability of the hemato-encephalic barrier for benzylpenicillin in experimental and clinical meningococcal meningitis. Antibiotiki 22: 926–929 (1977).
Ivanov, K.S.; Verovaia, A.V.; Popova, N.N. and Tiurin, A.G.: Effect of furosemide on the pharmacokinetics of benzyl-penicillin and its penetration through the hematoencephalic barrier in experimental and clinical meningococcic meningitis. Antibiotiki 22: 530–536 (1977).
Jacobs, S.A.; Bleyer, W.A.; Chabner, B.A. and Johns, D.G.: Altered plasma pharmacokinetics of methotrexate administered intrathecally. Lancet 1: 465–466 (1975).
Jain, R.K.; Wei, J. and Gullino, P.M.: Pharmacokinetics of methotrexate in solid tumors. Journal of Pharmacokinetics and Biopharmaceutics 7: 181–194 (1979).
Jancso, G.: A rapid fluorescence microscopic method for the study of the capillary DOPA-dopamine barrier. Journal of Neurochemistry 24: 579–580 (1975).
Jones, R.D.M. and Jones, J.G.: Intrathecal morphine: Naloxone reverses respiratory depression but not analgesia. British Medical Journal 281: 645–646 (1980).
Kaiser, A.B. and McGee, Z.A.: Aminoglycoside therapy of Gram-negative bacillary meningitis. New England Journal of Medicine 293: 1215–1220 (1975).
Kaiser, A.B.; Wright, P.F.; McGee, Z.A. and Dupont, W.D.: Intraventricular gentamicin in meningitis. Lancet 2: 252 (1980).
Kangas, L.; Kanto, J.; Siirtola, T. and Pekkarinen, A.: Cerebro-spinal-fluid concentrations of nitrazepam in man. Acta Pharmacologica et Toxicologica 41: 74–79 (1977a).
Kangas, L.; Kanto, J. and Erkkola, R.: Transfer of nitrazepam across the human placenta. European Journal of Clinical Pharmacology 12: 355–357 (1977b).
Kangas, L.; Iisalo, E.; Kanto, J.; Lehtinen, V.; Pynnönen, S.; Ruikka, I.; Salminen, J.; Sillanpää, M. and Syvälahti, E.: Human pharmacokinetics of nitrazepam: Effect of age and diseases. European Journal of Clinical Pharmacology 15: 163–170 (1979).
Kanto, J.; Kangas, L. and Siirtola, T.: Cerebrospinal-fluid concentrations of diazepam and its metabolites in man. Acta Pharmacologica et Toxicologica 36: 328–334 (1975).
Kaplan, S.L.; Mason, E.O. Jr; Garciak, H.; Kvernland, S.J.; Loiselle, E.M.; Anderson, D.C.; Mintz, A.A. and Feigin, R.D.: Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. Journal of Pediatrics 98: 152–157 (1981).
Karwacka, H.: Ultrastructural and biochemical studies of the brain and other organs in rats after chronic ethanol administration. I. Experimentelle Pathologie (Jena) 18: 118–126 (1980).
Kendall, B.E. and Pullicino, P.: Intravascular contrast injection in ischaemic lesions. II. Effect on prognosis. Neuroradiology 19: 241–243 (1980).
Kielholz, P. (Ed): Beta-Blockers and the Central Nervous System (Hans Huber, Bern 1977).
Klatzo, I.: Pathophysiological aspects of brain edema; in Reulen and Schürmann (Eds) Steroids and Brain Edema, pp.1–8 (Springer Verlag, Berlin 1972).
Kragh-Sørensen, P.; Eggert Hansen, C.; Baastrup, P.C. and Hvidberg, E.F.: Self-inhibiting action of nortriptylin’s anti-depressive effect at high plasma levels. Psychopharmacology 45: 305–312 (1976).
Lajtha, A. and Ford, D.H. (Eds): Progress in Brain Research, Vol. 29, Brain Barrier Systems (Elsevier, Amsterdam 1968).
Landesman, S.H.; Corrado, M.L.; Shah, P.M.; Armengaud, M.; Barza, M. and Cherubin, C.E.: Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in Gram-negative bacillary meningitis. American Journal of Medicine 71: 693–703 (1981).
Lankelma, J.; Lippens, R.J.J.; Drenthe-Schonk, A.; Termond, E.F.S. and Van der Kleijn, E.: Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults. Clinical Pharmacokinetics 5: 465–475 (1980).
Layfield, D.J.; Lemberger, R.J.; Hopkinson, B.R. and Makin, O.S.: Epidural morphine for ischaemic rest pain. British Medical Journal 282: 697–698 (1981).
Leo, A.; Hansch, C. and Elkins, D.: Partition coefficients and their uses. Chemical Reviews 71: 525–616 (1971).
Levin, V.A.; Landahl, H.D. and Freeman-Dove, M.A.: The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier. Journal of Pharmacokinetics and Biopharmaceutics 4: 499–519 (1976).
Lithander, A. and Lithander, B.: The passage of penicillin into the cerebrospinal fluid after parenteral administration in staphylococcic meningitis, Part I. Acta Pathologica Microbiologica Scandinavica 56: 435–450 (1962).
Lucek, R.W. and Coutinho, C.B.: The role of substituents in the hydrophobic binding of the 1,4-benzodiazepines by human plasma proteins. Molecular Pharmacology 12: 612–619 (1976).
MacDonell, L.A.; Potter, P.E. and Leslie, R.A.: Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs. Cancer Research 38: 2930–2934 (1978).
Matakas, F.; Birkle, J. and Cervos-Navarro, J.: The effect of prolonged experimental hypercapnia on the brain. Acta Neuropathologica (Berlin) 41: 207–210 (1978).
McAuliffe, J.J.; Sherwin, A.L.; Leppik, I.E.; Fayle, S.A. and Pippenger, C.E.: Salivary levels of anticonvulsants: A practical approach to drug monitoring. Neurology 27: 409–413 (1977).
McCracken, G.H., Jr and Mize, S.G.: Intraventricular gentamicin in meningitis (corresp). Lancet 2: 253–254 (1980).
McCracken, G.H.; Mize, S. and Threlkeld, N.: Intraventricular gentamicin therapy in Gram-negative bacillary meningitis of infancy. Lancet 1: 787–791 (1980).
Merker, P.C.; Mehta, B.M.; Cantor, M.L. and Hutchison, D.J.: Kinetics of elimination of methotrexate from the cerebrospinal fluid space of monkeys after ventriculolumbar perfusion. Cancer Treatmenl Reports 61: 603–611 (1977).
Mirkin, B.L.: Developmental pharmacology. Annual Reviews of Pharmacology 10: 255–272 (1970).
Mohanty, S.; Ray, A.K. and Dey, P.K.: Cerebral oedema and blood-brain and blood-CSF barriers in experimental brain trauma: Effect of indomethacin-A prostaglandin synthetase inhibitor. Indian Journal of Physiological Pharmacology 24: 91–96 (1980).
Morselli, P.L.; Baruzzi, A.; Gerna, M.; Bossi, L. and Porta, M.: Carbamazepine and carbamazepine-10,11-epoxide concentrations in human brain. British Journal of Clinical Pharmacology 4: 535–540 (1977).
Muscettola, G.; Goodwin, F.K.; Potter, W.Z.; Claeys, M.M. and Markey, S.P.: Imipramine and desipramine in plasma and spinal fluid. Archives of General Psychiatry 35: 621–625 (1978).
Myers, R.D.: Blood-brain barrier: Techniques for the intracerebral administration of drugs; in Iversen et al. (Eds) Handbook of Psychopharmacology Vol. 2, Sect. 1, Principles of Receptor Research, pp.1–28 (Plenum Press, New York 1975).
Myers, T.F.; Milsap, R.L.; Krauss, A.N.; Auld, P.A.M. and Reidenberg, M.M.: Low-dose theophylline therapy in idiopathic apnea of prematurity. Journal of Pediatrics 96: 99–103 (1980).
Neblett, C.R.; McNeel, D.P.; Waltz, T.A., Jr and Harrison, G.M.: Effect of cardiac glycosides on human cerebrospinal-fluid production. Lancet 2: 1008–1009 (1972).
Neil-Dwyer, G.; Bartlett, J.; McAinsh, J. and Cruickshank, J.M.: β-Adrenoceptor blockers and the blood-brain barrier. British Journal of Clinical Pharmacology 11: 549–553 (1981).
Norrby, R.: A review of the penetration of antibiotics into CSF and its clinical significance. Scandinavian Journal of Infectious Diseases (Suppl. 14): 296–309 (1978).
Norrby, R.: Pharmacokinetic aspects of the treatment of infections in the central nervous system. Journal of Antimicrobial Chemotherapy 5: 630–633 (1979).
Notkins, A.L.: Immune mechanisms by which the spread of viral infections is stopped. Cellular Immunology 11: 478–483 (1974).
Notkins, A.L. and Koprowski, H.: How the immune response to a virus can cause disease. Scientific American 228: 22–31 (1973).
O’Brien, M.D.; Jordan, M.M. and Waltz, A.G.: Ischemic cerebral edema and the blood brain barrier: Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery. Archives of Neurology 30: 461–465 (1974).
Odar-Cederlöf, I. and Borgå. O.: Kinetics of diphenylhydantoin in uraemic patients: Consequences of decreased plasma protein binding. European Journal of Clinical Pharmacology 7: 31–37 (1974).
O’Donoghue, S.E.F.: Distribution of pethidine and chlorpromazine in maternal, foetal and neonatal biological fluids. Nature 229: 124–125 (1971).
Oldendorf, W.H.: Brain uptake of radiolabelled amino acids, amines, and hexoses after arterial injection. American Journal of Physiology 221: 1629–1639 (1971).
Oldendorf, W.H.: Blood-brain barrier permeability to drugs. Annual Review of Pharmacology 14: 239–248 (1974a).
Oldendorf, W.H.: Lipid solubility and drug penetration of the blood brain barrier. Proceedings of the Society for Experimental Biology and Medicine 147: 813–816 (1974b).
Oldendorf, W.H. and Szabo, J.: Amino acid assignment to one of three blood-brain barrier amino acid carriers. American Journal of Physiology 230: 94–98 (1976).
Olsson, Y.: The involvement of vasa nervorum in diseases of peripheral nerves; in Vinken and Bruyn (Eds) Handbook of Clinical Neurology, Vol. 12, pp.644–664 (North Holland, Amsterdam 1972).
Osetowska, E.: Metals; in Minckler (Ed) Pathology of the Nervous System, Vol. 2, pp.1644–1651 (McGraw Hill, New York 1971).
Oyama, T.; Jin, T.; Yamaya, R.; Ling, N. and Guillemin, R.: Profound analgesic effects of β-endorphin in man. Lancet 1: 122–124 (1980).
Oyama, T.; Jin, T.; Yamaya, R.; Matsuki, A.; Guillemin, R. and Ling, N.: Intrathecal use of beta-endorphin as a powerful analgesic agent in man. Presented at Eighth International Congress of Pharmacology, Tokyo, July 19–24, 1981 (Abstr. S7-3).
Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Viloxazine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 13: 401–421 (1977).
Pollay, M.: Effect of hypertonic solutions on the blood-brain barrier. Neurology 25: 852–856 (1975).
Polnikorn, N.; Witoonpanich, R.; Vorachit, M.; Vejjajiva, S. and Vejjajiva, A.: Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. British Journal of Venereal Diseases 56: 363–367 (1980).
Posten, R.N. and Davies, D.F.: Immunity and inflammation in the pathogenesis of atherosclerosis: A review. Atherosclerosis 19: 353–367 (1974).
Price, R.A.: Histopathology of CNS leukemia and complications of therapy. American Journal of Pediatric Hematology/Oncology 1: 21–30 (1979).
Pynnönen, S.: Pharmacokinetics of carbamazepine in man: A review. Therapeutic Drug Monitoring 1: 409–431 (1979).
Rail, D.P.: Drug entry into brain and cerebrospinal fluid; in Brodie and Gillette (Eds) Handbook of Experimental Pharmacology, Vol. 28. Concepts in Biochemical Pharmacology, part 1, pp.240–248 (Springer Verlag, Berlin 1971).
Rapoport, S.I.: Experimental modification of blood-brain barrier permeability by hypertonic solutions, convulsions, hypercapnia and acute hypertension; in Cserr et al. (Eds) Fluid Environment of the Brain, pp.61–80 (Academic Press, New York 1975).
Rapoport, S.I.: Blood-Brain Barrier in Physiology and Medicine (Raven Press, New York 1976a).
Rapoport, S.I.: Opening of the blood-brain barrier by acute hypertension. Experimental Neurology 52: 467–479 (1976b).
Rapoport, S.I.: Osmotic opening of the blood-brain barrier; in Ciba Foundation Symposium (56), pp.237–255 (1978).
Rapport, R.L.; Harris, A.B.; Friel, P.N. and Penry, J.K.: Human epileptic brain. Na, K, ATPase activity and phenytoin concentrations. Archives of Neurology 32: 549–554 (1975).
Ratcheson, R.A. and Ommaya, A.K.: Experience with the subcutaneous cerebrospinal fluid reservoir preliminary report of 60 cases. New England Journal of Medicine 279: 1025–1031 (1968).
Reed, D.J.: Neurobiology: General principles related to epilepsy; in Glaser et al. (Eds) Antiepileptic Drugs: Mechanisms of Action, pp.199–206 (Raven Press, New York 1980).
Reivich, M.; Marshall, W.J.S. and Kassell, N.: Loss of autoregulation produced by cerebral trauma; in Brock et al. (Eds) Cerebral Blood Flow: Clinical and Experimental Results, pp.205–208 (Springer Verlag, Berlin 1969).
Repke, K. and Portius, H.J.: Uber die Identität der ionenpumpen-ATPase in der Zellmembran des Herzmuskels mit einem Digitalis-Receptorenzym. Experientia 19: 452–458 (1963).
Rieselbach, R.E.; Morse, E.E.; Rall, D.P.; Frei, E. III and Freireich, E.J.: Treatment of meningeal leukemia with intrathecal aminopterin. Cancer Chemotherapy Reports 16: 191–196 (1962).
Rosenblum, I. and Stein, A.A.: Preferential distribution of diphenylhydantoin in primary human brain tumors. Biochemical Pharmacology 12: 1453–1454 (1963).
Rosengren, L.E. and Persson, L.I.: Influence of ethanol and dexamethasone on blood-brain barrier dysfunction to albumin. Acta Neurologica Scandinavica 59: 119–126 (1979).
Rowland, M. and Tozer, T.N.: Clinical Pharmacokinetics: Concepts and Applications (Lea and Febiger, Philadelphia 1980).
Rubin, R.C.; Ommaya, A.K.; Henderson, E.S.; Bering, E.A. and Rall, D.P.: Cerebrospinal fluid perfusion for central nervous system neoplasms. Neurology 16: 680–692 (1966).
Rubin, R.; Owens, E. and Rall, D.: Transport of methotrexate by the choroid plexus. Cancer Research 28: 689–694 (1968).
Sadée, W.: Antineoplastic agents: High-dose methotrexate and citrovorum factor rescue; in Tognoni et al. (Eds) Frontiers in Therapeutic Drug Monitoring, pp.163–171 (Raven Press, New York 1980).
Salam, M.Z. and Sabra, F.: Pyogenic infections of the central nervous system; in Wintrobe et al. (Eds) Harrison’s Principles of Internal Medicine, 6th ed., Vol. 2, pp.1785–1792 (McGraw-Hill, New York 1970).
Samii, K.; Feret, J.; Harari, A. and Viars, P.: Selective spinal analgesia (corresp.) Lancet 1: 1142 (1979).
Samorajski, T. and Rolsten, C.: Age and regional differences in the chemical composition of brains of mice, monkeys and humans. Progress in Brain Research 40: 253–265 (1973).
Sande, M.A.: Antibiotic therapy of bacterial meningitis: Lessons we’ve learned. Am. J. Med. 71: 507–510 (1981).
Sathananthan, G.L.; Gershon, S.; Almeida, M.; Spector, N. and Spector, S.: Correlation between plasma and cerebrospinal levels of imipramine. Archives of General Psychiatry 33: 1109–1110 (1976).
Saunders, N.R. and Bradbury, M.W.B.: The development of the internal environment of the brain; in Boréus (Ed) Fetal Pharmacology, pp.93–109 (Raven Press, New York 1973).
Scarpignato, C.; Bertaccini, G.; Ceda, G.P. and Valenti, G.: Prolactin response to TRH after intravenous cimetidine. Farmaco(Sci) 34: 726–728 (1979).
Schanker, L.S.: Passage of drugs across body membranes. Pharmacological Reviews 14: 501–530 (1962).
Schentag, J.; Cerra, F.B.; Calleri, G.; De Glopper, E.; Bernhard, H. and Rose, J.Q.: Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1: 177–181 (1979).
Schliep, G.; Rapic, N. and Felgenhauer, K.: Quantitäten of high-molecular proteins in cerebrospinal fluid. Zeitschrift fur Klinische Chemie und Klinische Biochemie 12: 367–369 (1974).
Schmidt, D. and Kupferberg, H.J.; Diphenylhydantoin, phenobarbital and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia 16: 735–741 (1975).
Schobben, F.; van der Kleijn, E. and Vree, T.B.: Therapeutic monitoring of valproic acid; in Tognoni et al. (Eds) Frontiers in Therapeutic Drug Monitoring, pp.59–69 (Raven Press, New York 1980).
Shapiro, H.M.: Intracranial hypertension: Therapeutic and anesthetic considerations. Anesthesiology 43: 445–471 (1975).
Shapiro, W.R.; Young, D.F. and Mehta, B.M.: Methotrexate: Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. New England Journal of Medicine 293: 161–166 (1975).
Sherwin, A.L.; Eisen, A.A. and Sokolowski, C.D.: Anticonvulsant drugs in human epileptogenic brain correlation of phénobarbital and diphenylhydantoin levels with plasma. Archives of Neurology 29: 73–77 (1973).
Silbergeld, E.K.; Wolinsky, J.S. and Goldstein, G.W.: Electron probe microanalysis of isolated brain capillaries poisoned with lead. Brain Research 189: 369–376 (1980).
Sironi, V.A.; Cabrini, G.P.; Porro, M.G.; Ravagnati, L. and Marossero, F.: Antiepileptic drug distribution in cerebral cortex, Ammon’s horn and amygdala in man. Journal of Neurosurgery 52: 686–692 (1980).
Sjöqvist, F.; Bertilsson, L. and Ásberg, M.: Monitoring tricyclic antidepressants; in Tognoni et al. (Eds) Frontiers in Therapeutic Drug Monitoring, pp.83–92 (Raven Press, New York 1980).
Somani, S.M.; Khanna, N.N. and Bada, S.B.: Caffeine and theophylline: Serum/CSF correlation in premature infants. Journal of Pediatrics 96: 1091–1093 (1980).
Spagnoli, A. and Tognoni, G.: Cerebral vasodilators and cerebro-active drugs. Drugs. In press (1982).
Stanski, D.R.; Greenblatt, D.J.; Selwyn, A.; Shader, R.I.; Franke, K. and Koch-Weser, J.: Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clinical Pharmacology and Therapeutics 20: 571–578 (1976).
Steinwall, O.: Transport inhibition phenomena in unilateral chemical injury of blood-brain barrier. Progress in Brain Research 29: 357–365 (1968).
Stovner, J.; Endresen, R. and Osterud, A.: Intravenous anaesthesia with a new benzodiazepine Ro 5-4200. Acta Anaesthesiologica Scandinavica 17: 163–169 (1973).
Strausbaugh, L.J.; Girigis, N.I.; Mikhail, I.A.; Edman, D.C.; Miner, W.F. and Yassin, M.W.: Penetration of amoxicillin into cerebrospinal fluid. Antimicrobial Agents and Chemotherapy 14: 899–902 (1978).
Tackett, R.L.; Webb, J.G. and Privitera, P.J.: Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science 213: 911–913 (1981).
Taylor, E.A.; Jefferson, D.; Carroll, J.D. and Turner, P.: Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: Evidence for centra! actions of β-adrenoceptor antagonists. British Journal of Clinical Pharmacology 12: 549–559 (1981).
Tognoni, G.; Bellantuono, G; Bonati, M.; D’Incalci, M.; Gerna, M.; Latini, R.; Mandelli, M.; Porro, M.G. and Riva, E.: Clinical relevance of pharmacokinetics. Clinical Pharmacokinetics 5: 105–136 (1980).
Totte, J.; Scharpe, S.; Verkerk, R.; Neels, H.; Vanhaeverbeek, M.; Smitz, S. and Rousseau, J.J.: Neurological dysfunction associated with abnormal levels of cimetidine metabolite. Lancet 1: 1047 (1981).
Vajda, F.; Williams, F.M.; Davidson, S.; Falconer, M.A. and Breckenridge, A.: Human brain, cerebrospinal, and plasma concentrations of diphenylhydantoin and phenobarbital. Clinical Pharmacology and Therapeutics 15: 597–603 (1974).
Waal-Manning, H.J.: Hypertension: Which beta-blocker? Drugs 12: 412–441 (1976).
Wald, S.L. and McLaurin, R.L.: Cerebrospinal fluid antibiotic levels during treatment of shunt infections. Journal of Neurosurgery 52: 41–46 (1980).
Warren, R.E. and Roberton, N.R.C.: Intraventricular gentamicin in meningitis (corresp.). Lancet 2: 252 (1980).
Way, W.L.; Costley, E.C. and Way, E.X.: Respiratory sensitivity of the newborn infant to meperidine and morphine. Clinical Pharmacology and Therapeutics 6: 454–461 (1965).
Whiteside, J.A.; Philips, P.S.; Dargeon, H.W. and Burchenal, J.H.: Intrathecal amethopterin in neurological manifestations of leukemia. Archives of Internal Medicine 101: 279–285 (1958).
Wilson, H.D.; Bean, J.R.; James, H.E. and Pendley, M.M.: Cerebrospinal fluid antibiotic concentrations in ventricular shunt infections. Childs Brain 4: 74–82 (1978).
Yaffe, S.J. and Juchau, M.R.: Perinatal pharmacology. Annual Review of Pharmacology 14: 219–238 (1974).
Yaksh, T.L.: Opioid peptides and analgesia: Sites of action. Presented at Eighth International Congress of Pharmacology, Tokyo, July 19–24, 1981 (abstr. S7-2)
Zenz, M.; Schappler-Scheele, B.; Neuhaus, R.; Piepenbrock, S. and Hilfrich, J.: Long-term peridural morphine analgesia in cancer pain. Lancet 1: 91 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonati, M., Kanto, J. & Tognoni, G. Clinical Pharmacokinetics of Cerebrospinal Fluid. Clin Pharmacokinet 7, 312–335 (1982). https://doi.org/10.2165/00003088-198207040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198207040-00003